Suppr超能文献

[超抗原SEA与抗人大肠癌ND-1单克隆抗体单链Fv融合基因的构建、表达及鉴定]

[Construction, expression and characterization of the fusion gene of super-antigen SEA and single chain Fv of the ND-1 monoclonal antibody against human colorectal cancer].

作者信息

Chen Hang, Li Li, Fang Jin

机构信息

Department of Cell Biology, Key Labaratory of Cell Biology, Ministry of Public Health, and Key Labaratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang 110001, China.

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Apr;28(4):400-3.

Abstract

AIM

To construct and express the recombinant ND-1-scFv/SEA, a fusion protein of superantigen (staphylococcal enterotoxinA, SEA) and single-chain variable fragment of monoclonal antibody ND-1 against human clolorectal carcinoma, and to enhance the targeted killing effect of SEA.

METHODS

The expression of the fusion protein was induced in E.coli M15 by IPTG. Ni-NTA resin affinity chromatography was used to separate and purify the expressed product. The specific binding activity of the purified ND-1-scFv/SEA protein was examined by indirect immunofluorescence assay and the targeted-cytotoxicity was determined using MTT assay.

RESULTS

The expressing vector of fusion gene ND-1scFv/SEA was constructed successfully. ND-1-scFv/SEA protein retained a high binding affinity to antigen-positive human colorectal cancer cell CCL-187 and had a stronger capability to activate PBMC and kill the target cells compared to SEA alone, with a killing rate of 91% at 4 μg/mL.

CONCLUSION

ND-1-scFv/SEA fusion protein could specifically target colorectal cancer cell, enhance the activity of kill tumor cell and has potential applications in the targeted therapy of colorectal cancer.

摘要

目的

构建并表达超抗原(葡萄球菌肠毒素A,SEA)与人结肠癌单克隆抗体ND-1单链可变片段的融合蛋白重组ND-1-scFv/SEA,增强SEA的靶向杀伤作用。

方法

用异丙基-β-D-硫代半乳糖苷(IPTG)在大肠杆菌M15中诱导融合蛋白表达。采用镍-亚氨基二乙酸(Ni-NTA)树脂亲和层析法分离纯化表达产物。通过间接免疫荧光法检测纯化的ND-1-scFv/SEA蛋白的特异性结合活性,并用MTT法测定其靶向细胞毒性。

结果

成功构建融合基因ND-1scFv/SEA的表达载体。ND-1-scFv/SEA蛋白与抗原阳性的人结肠癌细胞CCL-187保持高结合亲和力,与单独的SEA相比,具有更强的激活外周血单个核细胞(PBMC)和杀伤靶细胞的能力,在4μg/mL时杀伤率为91%。

结论

ND-1-scFv/SEA融合蛋白可特异性靶向结肠癌细胞,增强杀伤肿瘤细胞的活性,在结肠癌的靶向治疗中具有潜在应用价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验